Mersana Therapeutics, Inc. Comparables
Find the most relevant public market comparables for Mersana Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Mersana Therapeutics is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The company has developed proprietary cytotoxic (Dolasynthen) and immunostimulatory (Immunosynthen) ADC platforms.
Business Model
Clinical-stage biopharmaceutical company developing and commercializing antibody-drug conjugates (ADCs) for cancer treatment.
Target Customers
Cancer patients with unmet needs.
Specific Focus
Antibody-drug conjugates (ADCs) for cancer treatment, specifically targeting areas of high unmet medical need.
Location
Cambridge, Massachusetts
CEO
Martin Huber, MD
Industry
Life sciences
Sub Sector
Biopharmaceutical
3yr Revenue Growth
4,351%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Mersana Therapeutics, Inc. in the Pharmaceuticals & Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Mersana Therapeutics, Inc.? Our platform provides detailed analysis of Mersana Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Mersana Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Mersana Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals & Biotechnology sector, Mersana Therapeutics, Inc. operates in the specialized Biopharmaceutical sub-sector. Understanding how Mersana Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biopharmaceutical space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Mersana Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free